PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)
Indonesia · Delayed Price · Currency is IDR 244.00
0.00 (0.00%)
Sep 2, 2026, 1:56 PM WIB
IDX:DGNS Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 176,486 | 166,624 | 163,072 | 145,696 | 192,886 | 302,182 | |
Revenue Growth | 11.06% | 2.18% | 11.93% | -24.46% | -36.17% | 64.97% |
Cost of Revenue | 92,791 | 88,341 | 90,998 | 86,384 | 99,127 | 153,626 |
Gross Profit | 83,694 | 78,283 | 72,074 | 59,312 | 93,759 | 148,555 |
Selling, General & Admin | 77,391 | 72,984 | 70,113 | 73,420 | 78,320 | 67,127 |
Other Operating Expenses | 681.39 | -829.79 | 36.37 | 1,043 | -1,660 | - |
Operating Expenses | 78,072 | 72,154 | 70,150 | 74,463 | 76,660 | 67,127 |
Operating Income | 5,622 | 6,129 | 1,924 | -15,151 | 17,099 | 81,429 |
Interest Expense | -1,151 | -775.6 | -881.83 | -475.24 | -628.02 | -331.52 |
Interest & Investment Income | 42.21 | 53.92 | 107.37 | 392.24 | 862.94 | 2,217 |
Other Non Operating Income (Expenses) | - | - | 0 | - | - | -35.1 |
EBT Excluding Unusual Items | 4,513 | 5,407 | 1,150 | -15,234 | 17,333 | 83,279 |
Gain (Loss) on Sale of Assets | - | -0.83 | -285.77 | 1,661 | - | - |
Pretax Income | 4,513 | 5,406 | 863.77 | -13,573 | 17,333 | 83,279 |
Income Tax Expense | 2,469 | 2,469 | 116.32 | 83 | 4,669 | 18,975 |
Net Income | 2,044 | 2,937 | 747.44 | -13,656 | 12,665 | 64,304 |
Net Income to Common | 2,044 | 2,937 | 747.44 | -13,656 | 12,665 | 64,304 |
Net Income Growth | - | 292.95% | - | - | -80.31% | 22.05% |
Shares Outstanding (Basic) | 1,313 | 1,250 | 1,250 | 1,250 | 1,250 | 1,240 |
Shares Outstanding (Diluted) | 1,313 | 1,250 | 1,250 | 1,250 | 1,250 | 1,240 |
Shares Change | 5.00% | - | - | - | 0.78% | 24.04% |
EPS (Basic) | 1.56 | 2.35 | 0.60 | -10.92 | 10.13 | 51.84 |
EPS (Diluted) | 1.55 | 2.35 | 0.60 | -10.92 | 10.00 | 51.84 |
EPS Growth | - | 292.95% | - | - | -80.71% | -1.60% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 4,195 | 2,585 | -16,095 | -25,141 | -40,052 | -8,966 |
Free Cash Flow Per Share | 3.20 | 2.07 | -12.88 | -20.11 | -32.04 | -7.23 |
Gross Margin | 47.42% | 46.98% | 44.20% | 40.71% | 48.61% | 49.16% |
Operating Margin | 3.19% | 3.68% | 1.18% | -10.40% | 8.87% | 26.95% |
Profit Margin | 1.16% | 1.76% | 0.46% | -9.37% | 6.57% | 21.28% |
Free Cash Flow Margin | 2.38% | 1.55% | -9.87% | -17.26% | -20.77% | -2.97% |
EBITDA | 13,928 | 14,911 | 13,688 | -3,604 | 26,494 | 86,244 |
EBITDA Margin | 7.89% | 8.95% | 8.39% | -2.47% | 13.74% | 28.54% |
D&A For EBITDA | 8,306 | 8,782 | 11,764 | 11,547 | 9,396 | 4,815 |
EBIT | 5,622 | 6,129 | 1,924 | -15,151 | 17,099 | 81,429 |
EBIT Margin | 3.19% | 3.68% | 1.18% | -10.40% | 8.87% | 26.95% |
Effective Tax Rate | 54.72% | 45.67% | 13.47% | - | 26.93% | 22.79% |
Advertising Expenses | - | 6,353 | 6,578 | 6,159 | 7,007 | 5,078 |